HLA-DRB1 and myeloid sarcoma: Thus, the relatively high proportion of DRB1*04:05 carriers in Japanese MS patients (approximately 30–40% in our previous report [31]) may explain the lower number of brain MRI lesions and lower degree of disability in this population.